Chie Moritani1, Kayoko Kawakami1, Hiroshi Shimoda2, Tadashi Hatanaka3, Etsuko Suzaki1, Seiji Tsuboi1. 1. School of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Okayama 703-8516, Japan. 2. Research and Development Division, Oryza Oil and Fat Chemical Co. Ltd., 1 Numata, Kitagata-cho, Ichinomiya-shi, Aichi 493-8001, Japan. 3. Okayama Prefectural Technology Center for Agriculture, Forestry, and Fisheries, Research Institute for Biological Sciences (RIBS), 7549-1 Yoshikawa, Kibi-chuo, Okayama 716-1241, Japan.
Abstract
We previously showed that commercially available rice peptide Oryza Peptide-P60 (OP60) increased the intracellular glutathione levels. This study aimed to evaluate the antioxidant potential of this peptide and assess its mechanism of action. Pretreatment of HepG2 cells with OP60 reduced the cytotoxicity caused by H2O2 or acetaminophen (APAP) (47.7 ± 1.3% or 12.2 ± 1.3% of the cytotoxicity for 5 mg/mL OP60 pretreatment compared to that in H2O2- or APAP-treated groups, respectively; p < 0.01) through the restoration of glutathione homeostasis. Moreover, OP60 elevated the mRNA level of genes encoding heavy and light subunits of γ-glutamylcysteine synthetase (γ-GCS) by 2.9 ± 0.1-fold and 2.7 ± 0.2-fold (p < 0.001), respectively, at 8 h and also increased the level of mRNA encoding other antioxidant enzymes. Besides, OP60 promoted Nrf2 nuclear translocation by 2.2 ± 0.3-fold (p < 0.05) after 8 h. Conversely, knockdown of Nrf2 inhibited the increase of the intracellular glutathione levels and suppressed the induction of antioxidant enzyme expression by OP60. In animal studies, OP60 prevented APAP-induced liver injury by suppressing glutathione depletion (from 0.19 ± 0.02 mmol/mg protein to 0.90 ± 0.02 mmol/mg protein; p < 0.01, by pretreatment with 500 mg/kg OP60) and increasing heavy subunit of γ-GCS and heme oxygenase-1 expression in the liver. Our results indicated that OP60 exhibits a cytoprotective effect via the Nrf2 signaling pathway and is one of the few peptides with excellent antioxidant properties.
We previously showed that commercially available rice peptide Oryza Peptide-P60 (OP60) increased the intracellular glutathione levels. This study aimed to evaluate the antioxidant potential of this peptide and assess its mechanism of action. Pretreatment of HepG2 cells with OP60 reduced the cytotoxicity caused by H2O2 or acetaminophen (APAP) (47.7 ± 1.3% or 12.2 ± 1.3% of the cytotoxicity for 5 mg/mL OP60 pretreatment compared to that in H2O2- or APAP-treated groups, respectively; p < 0.01) through the restoration of glutathione homeostasis. Moreover, OP60 elevated the mRNA level of genes encoding heavy and light subunits of γ-glutamylcysteine synthetase (γ-GCS) by 2.9 ± 0.1-fold and 2.7 ± 0.2-fold (p < 0.001), respectively, at 8 h and also increased the level of mRNA encoding other antioxidant enzymes. Besides, OP60 promoted Nrf2 nuclear translocation by 2.2 ± 0.3-fold (p < 0.05) after 8 h. Conversely, knockdown of Nrf2 inhibited the increase of the intracellular glutathione levels and suppressed the induction of antioxidant enzyme expression by OP60. In animal studies, OP60 prevented APAP-induced liver injury by suppressing glutathione depletion (from 0.19 ± 0.02 mmol/mg protein to 0.90 ± 0.02 mmol/mg protein; p < 0.01, by pretreatment with 500 mg/kg OP60) and increasing heavy subunit of γ-GCS and heme oxygenase-1 expression in the liver. Our results indicated that OP60 exhibits a cytoprotective effect via the Nrf2 signaling pathway and is one of the few peptides with excellent antioxidant properties.
Aerobic organisms constitutively
produce reactive oxygen species
(ROS) as a natural by-product of oxygen metabolism. Excessive ROS
production and impaired antioxidant defense potential cause an imbalance
in ROS metabolism, which leads to a pro-oxidative state termed as
oxidative stress. Oxidative stress is known to cause oxidative damage
to biological molecules, such as proteins, lipids, and DNA, compromising
cellular functions, thus playing an essential role in the development
of various pathological conditions, including cancer,[1] diabetes,[2] cardiovascular diseases,[3] and neurodegenerative disorders.[4] In order to prevent these physiological conditions, maintenance
of balance between cellular ROS generation and antioxidant defense
mechanisms is important.[5]In mammalian
cells, antioxidant molecules and antioxidant/detoxifying
enzymes act as defense systems in order to detoxify ROS or prevent
its excess production. Glutathione (GSH) is the most abundant and
important non-protein thiol-based antioxidant molecule in cells. GSH
alone, or together with GSH peroxidase, can remove H2O2, lipid peroxides, and free radicals. Moreover, it plays a
vital role in xenobiotic detoxification through direct thiol conjugation.
Thus, the ability of cells to maintain the GSH level is essential
to protect cellular function and integrity.[6] Biosynthesis of GSH occurs by two reactions, which are adenosine
triphosphate (ATP)-dependent.[7] The first
step, a rate-limiting enzyme in GSH biosynthesis, is catalyzed by
γ-glutamylcysteine synthetase (γ-GCS), and its expression
is mainly regulated by nuclear factor erythroid 2-related factor 2
(Nrf2).[8]Nrf2 also regulates the
expression of antioxidant and detoxifying
enzymes, such as heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase1
(NQO1), and glutathione reductase (GR). Therefore, Nrf2 acts as a
master regulator of cellular responses against environmental stresses.
Under basal conditions, Nrf2 is bound to Kelch-like ECH associated
protein 1 (Keap1) in the cytoplasm, which facilitates its degradation.
In response to oxidative stress, Nrf2 dissociates from Keap1, translocates
into the nucleus, and binds to antioxidant response elements (AREs)
in the nucleus, resulting in the upregulation of its target genes.[9,10] The activation of Nrf2 is expected to protect cells from oxidative
damage via the upregulation of antioxidant and detoxifying enzymes.In addition to vitamins, dietary fibers, polyphenols, and hydrolysates
derived from dietary proteins exhibit health-promoting effects, such
as antioxidant, antihypertensive, antidiabetic, anti-melanogenic,
and immunomodulating activities.[11,12] Recently,
antioxidant peptides from dietary sources have drawn significant attention.
Protein hydrolysates enzymatically produced from proteins of fish,
milk, egg, soybean, whey, among others, have been reported to act
as direct antioxidants by scavenging ROS and free radicals or sequestering
pro-oxidant metals through chelation.[13,14] Although the
actions of these peptides as direct antioxidants are well-known, the
current understanding of how peptides act as indirect antioxidants
and activate the Keap1-Nrf2 pathway is limited. Fish skin gelatin-derived
protein hydrolysates[15] and a tripeptide
from Chinese Baijiu[16] reportedly induce
GSH synthesis through Nrf2 pathway activation. We reported that rice
bran protein hydrolysate increases intracellular GSH levels in the
HepG2humanhepatoblastoma cells.[17] Additionally,
rice-derived peptides and sake lees hydrolysate are hepatoprotective
in the case of acetaminophen (APAP)-induced liver injury.[18,19] These antioxidative effects were suggested to be mediated through
the Nrf2 antioxidant pathway. However, only a few peptides have been
shown to act as indirect antioxidants by regulating the oxidative
defense systems. Besides, peptides derived from eggshell membrane
and chickpeas protein hydrolysates were shown to upregulate antioxidant
enzymes.[20,21] However, the mechanisms of the antioxidant
action of these peptides are yet to be fully determined.In
our previous study, we have shown that a commercially available
rice peptide Oryza Peptide-P60 (OP60) increased intracellular GSH
levels.[22] However, its protective effects
against oxidative stress and the underlying antioxidant mechanism
are yet to be investigated. In this study, the cytoprotective effect
of OP60 against H2O2 and APAP-induced oxidative
stress in HepG2 cells was determined. The OP60 antioxidant mechanism
was assessed through the activation of Nrf2, which is a pivotal regulator
of the expressions of several antioxidant enzymes. Furthermore, the
protective effect of OP60 against APAP-induced hepatic injury in mice
was evaluated. This study provided information about the molecular
mechanisms underlying the indirect antioxidative effects of OP60.
Results
Protective Effects of OP60
against H2O2- or APAP-Induced Cytotoxicity in
HepG2 Cells
Cytotoxicity was evaluated by measuring the activity
of released
LDH from damaged cells in the medium. The cells were treated with
or without OP60 followed by exposure to 200 μM H2O2 or 10 mM APAP. An overdose of APAP is known to cause
an increase in the level of N-acetyl-p-benzoquinone imine (NAPQI), which is a reactive metabolite formed
from APAP by cytochrome P450. At low amounts, NAPQI is efficiently
detoxified via conjugation with GSH. However, excess NAPQI causes
oxidative stress by binding to cellular macromolecules and depleting
GSH, ultimately leading to apoptosis and hepatic necrosis.[23,24] The treatment of control cells with H2O2 resulted
in cytotoxicity of 77.9 ± 3.0%. However, pretreatment with OP60
effectively protected the cells in a dose-dependent manner (Figure A). Similarly, treatment
with APAP caused 27.6 ± 2.0% cytotoxicity, which was significantly
reduced in cells pretreated with OP60 in a dose-dependent manner (Figure B). Since OP60 has
been previously observed to increase the intracellular GSH levels,
total GSH levels were determined under the condition of H2O2- and APAP-induced oxidative stress. Treatment with
H2O2 alone decreased the GSH levels after 2
h (Figure C). In cells,
the ratio of GSH/GSSG tended to decrease, indicating an imbalance
of the intracellular redox status (Figure D). Pretreatment with OP60 restored the decreased
in the total GSH levels and GSH/GSSG ratio to the control levels (Figure C,D). The intracellular
GSH level in cells exposed to APAP alone was 0.86 ± 0.05-fold
of the control, although significant depletion of the intracellular
GSH level was not observed in cells exposed to APAP. APAP added to
OP60 significantly increased the intracellular GSH level compared
to OP60 treatment alone (Figure E). Similarly, in APAP-treated cells, the decreased
GSH/GSSG ratio was significantly increased by OP60 pretreatment (Figure F). These results
suggested that OP60 protected the cells from oxidative stress induced
by H2O2 and APAP mainly by maintaining the intracellular
redox homeostasis.
Figure 1
Protective effect of OP60 against cell damage caused by
oxidative
stress in HepG2 cells. (A) Cells were pretreated with 5 mg/mL OP60
for 24 h and then exposed to 200 μM H2O2 for 24 h. (B) Cells were pretreated with 5 mg/mL OP60 for 24 h and
then exposed to 10 mM APAP for 24 h. The cytotoxicity was determined
by measurement of LDH activity released from damaged cells into the
medium. HepG2 cells were treated with 5 mg/mL OP60 for 24 h and then
treated with or without 200 μM H2O2/10
mM APAP for 2 h and harvested for measurement of (C, E) total GSH
and (D, F) GSH/GSSG ratio. Data shown represent the mean values of
three experiments ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 vs control
group. Values with the same letter are not significantly different
(p < 0.05) according to Tukey’s multiple
test.
Protective effect of OP60 against cell damage caused by
oxidative
stress in HepG2 cells. (A) Cells were pretreated with 5 mg/mL OP60
for 24 h and then exposed to 200 μM H2O2 for 24 h. (B) Cells were pretreated with 5 mg/mL OP60 for 24 h and
then exposed to 10 mM APAP for 24 h. The cytotoxicity was determined
by measurement of LDH activity released from damaged cells into the
medium. HepG2 cells were treated with 5 mg/mL OP60 for 24 h and then
treated with or without 200 μM H2O2/10
mM APAP for 2 h and harvested for measurement of (C, E) total GSH
and (D, F) GSH/GSSG ratio. Data shown represent the mean values of
three experiments ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 vs control
group. Values with the same letter are not significantly different
(p < 0.05) according to Tukey’s multiple
test.
Effect
of OP60 on Antioxidant Enzymes Expression
Since the protective
effects of OP60 appeared to be related to
its antioxidant potential, the mRNA levels of γ-GCSh and γ-GCSl genes, which encode heavy and
light subunits of the rate-limiting enzyme in GSH synthesis, were
determined. As expected, the expression of both genes began to increase
at 3 h and reached maximum levels (2.9 ± 0.1-fold and 2.7 ±
0.2-fold, respectively) at 8 h after the addition of OP60 (Figure A). Moreover, following
OP60 treatment, the protein level of γ-GCSh was found to be
increased at 8 h with a significantly higher increase of 2.7 ±
0.5-fold at 24 h (Figure B).
Figure 2
Effect of OP60 on γ-GCS expression. (A) Real-time PCR analyses
of heavy (γ-GCSh) and light (γ-GCSl) subunits of γ-GCS. (B) Western blot analysis
of γ-GCSh in HepG2 cells treated with 5 mg/mL OP60 for the indicated
periods. Data shown represent the mean values of three experiments
± SEM. *p < 0.05 and ***p < 0.001 vs control group.
Effect of OP60 on γ-GCS expression. (A) Real-time PCR analyses
of heavy (γ-GCSh) and light (γ-GCSl) subunits of γ-GCS. (B) Western blot analysis
of γ-GCSh in HepG2 cells treated with 5 mg/mL OP60 for the indicated
periods. Data shown represent the mean values of three experiments
± SEM. *p < 0.05 and ***p < 0.001 vs control group.Expression of HO-1, NQO1, and GR genes, which are mainly regulated by Nrf2, was also checked.
It was observed that, among the three genes, HO-1 was the most strongly induced. Its mRNA expression was induced at
1 h after treatment with OP60 and significantly increased by 17.0
± 0.6-fold at 8 h, whereas NQO1 and GR mRNAs levels were induced at 3 h after OP60 exposure,
and at 16 h, the expression of these genes increased by 2.2 ±
0.1-fold and 1.7 ± 0.1-fold, respectively (Figure A). Similarly, treatment with OP60 strongly
induced HO-1 protein expression, which was significantly increased
by 30-fold at 16 and 24 h (Figure B).
Figure 3
Effect of OP60 on the expression of antioxidant enzymes.
(A) Real-time
PCR analyses of HO-1, NQO1, and GR. (B) Western blot analysis of HO-1 in HepG2 cells treated
with 5 mg/mL OP60 for the indicated periods. Data shown represent
the mean values of three experiments ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 vs control group.
Effect of OP60 on the expression of antioxidant enzymes.
(A) Real-time
PCR analyses of HO-1, NQO1, and GR. (B) Western blot analysis of HO-1 in HepG2 cells treated
with 5 mg/mL OP60 for the indicated periods. Data shown represent
the mean values of three experiments ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 vs control group.
Effects of OP60 on Nrf2 Expression
Since
the mRNA and protein expression of antioxidant enzymes was
induced by OP60, the expression levels of Nrf2, which is a crucial
regulator for antioxidant enzymes, were determined. Nrf2 mRNA expression was observed to be induced at 1 h and increased
significantly by 1.2 ± 0.1-fold at 8 h, which was followed by
a gradual decrease to its basal levels (Figure A). In the total cell lysate, Nrf2 protein
levels started to increase at 1 h and further increased by 3.2 ±
0.2-fold at 8 h (Figure B). Similarly, nuclear Nrf2 protein expression was induced at 1 h
followed by its significant increase by 2.2 ± 0.3 fold at 8 h
(Figure C). Conversely,
the levels of Nrf2 in the cytosolic fraction remained unchanged. These
observations indicated that OP60 treatment stabilized Nrf2 and induced
its translocation into the nucleus.
Figure 4
Effect of OP60 on Nrf2 expression. (A)
Real-time PCR analysis of Nrf2 and its western blot
analysis from (B) cell lysate
and (C) the cytosolic or nuclear fraction of HepG2 cells treated with
5 mg/mL OP60 for the indicated periods. Data shown represent the mean
values of three experiments ± SEM. *p < 0.05
and **p < 0.01 vs control group.
Effect of OP60 on Nrf2 expression. (A)
Real-time PCR analysis of Nrf2 and its western blot
analysis from (B) cell lysate
and (C) the cytosolic or nuclear fraction of HepG2 cells treated with
5 mg/mL OP60 for the indicated periods. Data shown represent the mean
values of three experiments ± SEM. *p < 0.05
and **p < 0.01 vs control group.
Role of Nrf2 in OP60-Mediated Increase in
Intracellular GSH and Antioxidant Enzymes
To determine whether
the OP60-mediated increase in the levels of GSH and antioxidant enzymes
occurs via Nrf2 activation, Nrf2 or control siRNAs were transiently
transfected HepG2 cells. The Nrf2 mRNA level was
effectively reduced to less than 50% in cells transfected with Nrf2
siRNA (Figure A).
Knockdown of the Nrf2 gene significantly suppressed
the levels of OP60-induced intracellular GSH (Figure B) and γ-GCSh and HO-1 mRNA expressions (Figure C,D). These results suggested that the induction
of GSH synthesis and antioxidant enzymes occurs through a mechanism
by which the Nrf2 pathway is consecutively activated.
Figure 5
Effect of Nrf2 knockdown
on the induction of intracellular GSH
levels and antioxidant enzymes expression. Cells were transfected
with control or Nrf2 siRNAs and incubated for 48 h. After further
incubation in fresh medium with or without 5 mg/mL OP60 for 24 h,
cells were harvested for real-time PCR in order to evaluate (A) Nrf2, (C) γ-GCSh, and (D) HO-1 expressions and (B) intracellular GSH levels. Data
shown represent the mean values of three experiments ± SEM. **p < 0.01 and ***p < 0.001 vs control
siRNA group treated with OP60, ##p < 0.01 vs Nrf2
siRNA group without OP60.
Effect of Nrf2 knockdown
on the induction of intracellular GSH
levels and antioxidant enzymes expression. Cells were transfected
with control or Nrf2 siRNAs and incubated for 48 h. After further
incubation in fresh medium with or without 5 mg/mL OP60 for 24 h,
cells were harvested for real-time PCR in order to evaluate (A) Nrf2, (C) γ-GCSh, and (D) HO-1 expressions and (B) intracellular GSH levels. Data
shown represent the mean values of three experiments ± SEM. **p < 0.01 and ***p < 0.001 vs control
siRNA group treated with OP60, ##p < 0.01 vs Nrf2
siRNA group without OP60.
Effect of OP60 Treatment against APAP-Induced
Liver Injury in Mice
The cytoprotective effect of OP60 in
HepG2 cells was further assessed in vivo using an
APAP-induced liver injury model. No significant changes were observed
in body weight between the groups during the 7 days of treatment (data
not shown). APAPoverdose significantly increased the serum levels
of AST and ALT from 28.1 ± 0.8 and 4.4 ± 0.5 Karmen units
to 3745.3 ± 535.1 and 1917.0 ± 262.9 Karmen units, respectively,
which indicated liver injury. However, the administration of OP60
(500 mg/kg) effectively reduced the serum levels of these hepatic
marker enzymes to 2058.6 ± 165.5 (for AST) and 1154.1 ±
166.5 (for ALT) Karmen units, respectively (Figure A,B). Additionally, APAP increased the LDH
and ALP levels (256.2 ± 33.6 U/mL and 111.1 ± 7.8 U/mL,
respectively) compared to those in the control group (4.8 ± 0.6
U/mL and 61.5 ± 6.4 U/mL, respectively). OP60 administration
decreased the levels of LDH and ALP to 169.0 ± 14.5 U/mL and
63.0 ± 9.8 U/mL, respectively (Figure C,D). The levels of serum marker enzymes
did not change in mice treated with OP60 alone.
Figure 6
Protective effect of
OP60 against APAP-induced liver injury in
mice. The serum levels of (A) AST, (B) ALT, (C) LDH, and (D) ALP were
determined in mice with APAP-induced liver injury. Data shown represent
the mean values of six mice per group ± SEM. *p < 0.05 and **p < 0.01 vs APAP-treated group.
(E) Representative images of H&E staining of liver sections from
the control group, OP60-treated (500 mg/kg) group, APAP-treated group,
and OP60 (250 and 500 mg/kg) plus APAP-treated groups (original magnification,
400×). Arrowhead: multiple and extensive areas of hepatocellular
vacuolation.
Protective effect of
OP60 against APAP-induced liver injury in
mice. The serum levels of (A) AST, (B) ALT, (C) LDH, and (D) ALP were
determined in mice with APAP-induced liver injury. Data shown represent
the mean values of six mice per group ± SEM. *p < 0.05 and **p < 0.01 vs APAP-treated group.
(E) Representative images of H&E staining of liver sections from
the control group, OP60-treated (500 mg/kg) group, APAP-treated group,
and OP60 (250 and 500 mg/kg) plus APAP-treated groups (original magnification,
400×). Arrowhead: multiple and extensive areas of hepatocellular
vacuolation.Furthermore, histological examination
of liver sections obtained
from the mice in different groups indicated the protective effect
of OP60 against APAP-induced liver injury (Figure E). The liver from the control and OP60-treated
mice showed a typical lobular architecture and cell structure. However,
APAP treatment induced multiple extensive areas of hepatocellular
vacuolation, which were randomly distributed throughout the parenchyma,
whereas OP60 pretreatment ameliorated the APAP-induced liver damage.APAPoverdose is also known to induce the depletion of GSH in the
liver. Pretreatment with OP60 significantly recovered APAP-induced
glutathione depletion 6 h after APAP administration (Table ). These results indicated that
OP60 effectively improved APAP-induced liver injury.
Table 1
Effect of OP60 on Hepatic GSH Levels
in Mice with APAP-Induced Liver Injurya
groups
total GSH (nmol/mg protein)
control
34.9 ± 0.8
OP60 (500 mg/kg)
39.0 ± 0.8
APAP
0.19 ± 0.02##
APAP + OP60 (250 mg/kg)
0.52 ± 0.10**,
##
APAP + OP60 (500 mg/kg)
0.90 ± 0.11**,
##
Data shown represent the mean values
of six experiments ±SEM. ##p < 0.01 vs control
group. **p < 0.01 vs APAP-treated group.
Data shown represent the mean values
of six experiments ±SEM. ##p < 0.01 vs control
group. **p < 0.01 vs APAP-treated group.
Effect of OP60 Treatment
on γ-GCS and
HO-1 Protein Expression Levels in the Liver of APAP-Exposed Mice
Since OP60 increased the intracellular GSH levels via activating
the Nrf2 pathway in HepG2 cells, we predicted that the protective
effect of OP60 against APAP-induced liver injury is associated with
Nrf2. Thus, to test this prediction, the protein expression of γ-GCSh
and HO-1 was determined by western blotting. It was observed that
the protein expression of γ-GCSh was not affected by OP60 and
APAP treatments separately, but an overdose of APAP after the administration
of OP60 increased expression by 2.0 ± 0.6-fold. HO-1 protein
expression was induced by APAP alone and further increased by 5.4
± 0.3-fold by pretreatment with OP60. APAP treatment in addition
to OP60 increased the expression levels of these proteins. These results
suggested that OP60 exerted protective effects on APAP-induced liver
injury by attenuating the depletion of GSH through the upregulation
of γ-GCS expression and the induction of HO-1 expression, which
is known to be a cytoprotective protein.
Discussion
GSH is the most abundant non-protein thiol in cells and plays a
vital role in the antioxidant defense mechanism. We previously demonstrated
that OP60, a rice-derived peptide, increased intracellular GSH levels.[22] To evaluate the effect of OP60 on cytotoxicity
induced by oxidative stress, HepG2 cells were treated with H2O2 and APAP as oxidizing agents. Pretreatment of cells
with OP60 increased the viability of HepG2 cells against oxidative
stress-induced by H2O2 or APAP (Figure A,B). By determining GSH levels
and its redox status, it was observed that oxidative stress-mediated
reductions in GSH levels or GSH/GSSG ratio were restored by OP60 treatment,
suggesting that OP60 pretreatment can attenuate oxidative stress (Figure C–F).Next, the mechanism underlying the antioxidant action of OP60 was
explored. OP60 was observed to induce the expression of γ-GCS,
which is the rate-limiting enzyme in GSH biosynthesis. Variation in
the mRNA expression pattern of genes encoding both γ-GCS subunits (γ-GCSh and γ-GCSl) was similar at different time points (Figure A). In addition to γ-GCS genes, the expression of genes encoding antioxidant enzymes, such
as HO-1, NQO1, and GR, which are known to be positively regulated by Nrf2 were induced
by OP60 (Figure A,B).
Moreover, Nrf2 levels were slightly elevated in whole-cell lysates
and nuclear extracts at 1 h after OP60 addition, reaching a maximum
level at 8 h, which corresponded to the expression of antioxidant
enzymes (Figure A–C).
These results suggested that OP60 was able to stabilize the Nrf2 protein
and induce its nuclear translocation in order to exert antioxidant
effect by upregulating the expression of its target genes, including γ-GCS, HO-1, NQO1, and GR. The response of HO-1 mRNA
expression was faster and stronger than the responses of the other
genes of antioxidative enzymes. The HO-1 gene has
been reported to directly regulate stress-responsive transcription
factors, heat shock factor (HSF), nuclear factor−κB (NF-κB),
and activator protein–1 (AP-1) in addition to Nrf2.[25] The response of HO-1 mRNA expression
may be related to regulation by other transcription factors.In addition, knockdown of the Nrf2 gene suppressed
the increase of the intracellular GSH levels (Figure B) and the expressions of γ
-GCSh and HO-1 that were induced by OP60
treatment (Figure C,D). These results strongly suggested that OP60 upregulated GSH
biosynthesis and increased the expression of antioxidant enzymes via
activation of the Nrf2 pathway.Although many compounds derived
from natural products, such as
polyphenols, isothiocyanates, and resveratrol, have been reported
to be activators of the Nrf2 pathway,[26,27] very few peptides
have been shown to induce an Nrf2-mediated antioxidant response. Recently,
bioactive peptides of fish skin gelatin hydrolysate (FSGHF3) were
reported to be translocated into cells by Pept1, an oligopeptide transporter,
and exert antioxidant effects through activation of the Nrf2 pathway.[15] Regarding the mechanism, FSGHF3 increased Nrf2-mediated
expression of antioxidant enzymes through p62, an upstream regulator
of Nrf2.[28] A tripeptide from Chinese Baijiu
(Pro-His-Pro, PHP) was shown to protect the cells against oxidative
stress via the Nrf2 signaling pathway and was considered to decrease
the affinity of Nrf2 and Keap1.[16] Although
the interaction target might be different between FSGHF3 and PHP,
it was indicated that the expression level of Keap1 protein is reduced
when the expression of antioxidant enzymes including Nrf2 is induced
by the peptide. In this study, OP60 was also demonstrated to exhibit
an antioxidative effect via the Nrf2 signaling pathway. However, we
still need to evaluate the changes of Keap1, a critical factor, and
Nrf2 with respect to the oxidative response upon their exposure to
OP60 and how the active peptides in OP60 leads to the activation of
the Nrf2 pathway.OP60 showed an antioxidative effect at a concentration
of 2.5 or
5 mg/mL in HepG2 cells. Protein hydrolysates from rice bran,[17] rice,[18] eggshell
membrane,[20] chickpea,[21] and FSGHF3,[15] which are the
mixtures of peptides, have been reported to increase the intracellular
GSH levels and upregulate antioxidative enzymes in cells at a range
from 0.1 to 5 mg/mL. For example, treatment with 5 mg/mL rice bran-hydrolysate
for 24 h increased intracellular GSH levels in HepG2 cells by ca.
2-fold.[17] A 12 h treatment with 2.5 or
5 mg/mL FSGHF3 increased mRNA levels of γ-GCSh by ca. 2.3-fold and intracellular GSH levels by 1.3-fold in IPEC-J2
cells.[15] OP60 showed similar bioactivity
to these protein hydrolysates. In our previous study, we identified
a peptide (Pep3, YQQQFQQFLPEGQSQSQK) from OP60 that restores the activity
of the serotonin N-acetyltransferase enzyme after
it is inactivated by H2O2 treatment.[22] In the same study, Pep3 was shown to increase
the intracellular GSH levels in HepG2 cells at 10 μg/mL. Preliminary
results showed that Pept3 induces mRNA expression of γ-GCSh but not that of HO-1 (data not shown), whereas
OP60 itself markedly induced the HO-1 expression (Figure A,B). These observations suggest
that OP60 contains other bioactive peptides. We are attempting to
identify the active peptides by evaluating both the activation of
NQO1 activity and an increase in intracellular GSH level in HepG2
cells. The activity was recovered in 40% acetonitrile elution fraction
upon performing a C18 reversed-phase cartridge (data not shown). Thus,
further study is needed to identify the sequences of active peptides
of OP60, which can exert antioxidative activity at lower concentrations
such as observed with Pep3, and to better understand the mechanism
through which Nrf2 is activated in response to OP60 treatment.The antioxidant and hepatoprotective effect of OP60 was also demonstrated
in mice with APAP-induced hepatic injury. The increased serum levels
of AST, ALT, LDH, and ALP induced by APAPoverdose were reduced in
mice administered OP60 (Figure A–D). hematoxylin and eosin (H&E) staining of liver
sections showed that OP60 decreased hepatic vacuolation (Figure E). These in vivo results indicated the protective effect of OP60
against APAP-induced liver injury. Furthermore, the administration
of OP60 to mice significantly inhibited the APAP-induced GSH depletion
(Table ) and induced
γ-GCS and HO-1 expression compared to those in mice treated
with APAP alone (Figure ). HO-1 converts heme into carbon monoxide, free iron, and biliverdin,
which is rapidly reduced to bilirubin, a potent antioxidant.[29] Some natural products, such as sulforaphane
and caffeic acid, have been shown to exert protective effects against
APAP-induced liver injury based on their ability to induce antioxidant
responses mediated by the upregulation of the expression of Nrf2-target
genes such as HO-1 in addition to the inhibition
of GSH depletion.[30,31] Our results suggested that OP60
attenuates liver injury induced by APAP through activation of the
Nrf2-mediated antioxidant response. Indeed, there is a report on the
high sensitivity of Nrf2-knockout mice to APAP-induced hepatotoxicity.[32]
Table 3
Primer Sequences
Used for Real-Time
PCR
gene
forward primer
reverse primer
γ-GCSh
TGCTGTCTCCAGGTGACATTC
CCCAGCGACAATCAATGTCT
γ-GCSl
TCCAGTTCCTGCACATCTACCA
TCATCGCCCCACTTGAGAA
HO-1
GCAACCCGACAGCATGC
TGCGGTGCAGCTCTTCTG
NQO1
CATGAATGTCATTCTCTGGCCA
CTGGAGTGTGCCCAATGCTA
GR
ATGATCAGCACCAACTGCAC
CGACAAAGTCTTTTTAACCTCCTT
Nrf2
TGCTTTATAGCGTGCAAACCTCGC
ATCCATGTCCCTTGACAGCACAGA
β-actin
CCTGGCACCCAGCACAAT
GCCGATCCACACGGAGTACT
Figure 7
Effect of OP60 on the expression levels of γ-GCS
and HO-1
in the liver of mice. (A) Western blot analysis of the protein expression
of γ-GCSh and HO-1 after 6 h of APAP treatment. Lane 1: Control;
Lane 2: OP60 (500 mg/kg); Lane 3: APAP; Lane 4: APAP + OP60 (250 mg/kg);
and Lane 5: APAP + OP60 (500 mg/kg). (B) Densitometric analysis of
western blots. Data shown represent the mean values of six mice per
group ± SEM. *p < 0.05 and **p < 0.01 vs APAP-treated group.
Effect of OP60 on the expression levels of γ-GCS
and HO-1
in the liver of mice. (A) Western blot analysis of the protein expression
of γ-GCSh and HO-1 after 6 h of APAP treatment. Lane 1: Control;
Lane 2: OP60 (500 mg/kg); Lane 3: APAP; Lane 4: APAP + OP60 (250 mg/kg);
and Lane 5: APAP + OP60 (500 mg/kg). (B) Densitometric analysis of
western blots. Data shown represent the mean values of six mice per
group ± SEM. *p < 0.05 and **p < 0.01 vs APAP-treated group.It is widely known that an overdose of APAP induces severe hepatotoxicity
by the formation of large amounts of NAPQI, which can bind to cellular
proteins and induce GSH depletion.[23,24] In the current
study, GSH levels in the mouse liver were depleted by an overdose
of APAP (Table ),
but even cytotoxic doses of APAP did not alter the intracellular GSH
levels in HepG2 cells (Figure E). Recently, Behrends et al. reported that intracellular
GSH was not depleted in HepG2 cells treated with 5 mM APAP for 24
h, whereas cell death was induced.[33] They
suggested that any redox stress subsequent to APAP exposure might
be due to the reduced production of NADPH rather than the consumption
of reducing equivalents by reactive species. It was reported that
the NADPH production pathway is also activated by Nrf2.[34] Restoring NADPH levels by OP60 might contribute
to the attenuation of cytotoxicity in HepG2 cells. Unexpectedly, treatment
with APAP for 2 h in addition to OP60 for 24 h increased the intracellular
GSH level higher than that of only OP60 treatment (Figure E). It was reported that NAPQI
could activate the Nrf2 signaling pathway via the direct modification
of cysteine residues in Keap1.[35] Activation
of the Nrf2 signaling pathway by NAPQI might contribute to the increase
in intracellular GSH level in addition to activation by OP60.
Conclusions
In summary, OP60 induced GSH synthesis
and antioxidant enzymes
through activation of the Nrf2 pathway, leading to the suppression
of oxidative stress-induced hepatotoxicity in vitro and in vivo. This study suggested that OP60 contained
crucial peptides with substantial antioxidant activities. Thus, it
could be potentially served as a functional food for the prevention
of diseases associated with oxidative stress.
Materials
and Methods
Chemicals
The commercial rice peptide
OP60 was a gift from Oryza Oil and Fat Chemical Co., Ltd. (Aichi,
Japan). OP60 is a water-soluble rice peptide produced by the enzymatic
decomposition of rice protein. The peptide content in OP60 is 68.5%,
along with 26.7% carbohydrate, 1.0% fiber, 0.1% fat, and 4.6% ash.
The tripeptide content of OP60 was estimated to be approximately 50%.
Amino acid composition, which was determined based on ion-exchange
chromatography followed by post-column derivatization with ninhydrin,
is shown Table .
Table 2
Amino Acid Composition of OP60
amino acid
amino acid
content (g/100 g)
arginine
6.73
lysine
2.14
histidine
1.81
phenylalanine
3.09
tyrosine
2.49
leucine
4.45
isoleucine
2.16
methionine
0.88
valine
3.33
alanine
3.31
glycine
2.77
proline
2.79
glutamic acid
11.20
serine
3.11
threonine
2.08
aspartic acid
5.85
tryptophan
0.39
cystine
0.79
Acetaminophen was purchased from Sigma (St. Louis,
MO, USA). 5,5′-Dithiobis-(2-nitrobenzoic
acid) (DTNB) was procured from Fujifilm Wako Pure Chemical (Osaka,
Japan). NADPH and yeastGR were purchased from Oriental Yeast Co.,
Ltd. (Tokyo, Japan). 7-Benzo-2-oxa-1,3-diazole-4-sulfonic acid (SBD-F)
and 4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole (ABD-F) were obtained
from Dojindo Labs (Kumamoto, Japan). Primary antibodies against γ-GCSh,
Nrf2, and Lamin B2 were purchased from Santa Cruz Biotechnology (Dallas,
TX, USA). Primary antibodies against HO-1 and β-actin were obtained
from Enzo Life Sciences (Farmingdale, NY) and Sigma (St. Louis, MO,
USA), respectively. The protein assay kit was obtained from Bio-Rad
Laboratories Inc. (Hercules, CA, USA).
Cell
Culture
HepG2 cells were purchased
from the RIKEN Cell Bank (Tsukuba, Japan) and were maintained in Eagle’s
minimum essential medium (MEM) supplemented with 10% fetal bovine
serum (FBS), 100 μg/mL streptomycin, 100 μg/mL penicillin,
and 0.56 μg/mL amphotericin B in a humidified atmosphere containing
5% CO2 at 37 °C. Cells were seeded into 6-well plates
(Thermo Fisher Scientific, Waltham, MA, USA) at a density of 1.5 ×
105 cells/well and were treated with 5 mg/mL OP60 for the
indicated periods. After incubation, cells were harvested for western
blot analysis and total RNA preparation.
Lactate
Dehydrogenase (LDH) Cytotoxicity Assay
The activity of LDH
released from damaged cells into the medium
was measured using a Cytotoxic Detection Kit (Roche Applied Science,
Mannheim, Germany). HepG2 cells were seeded in 96-well microplates
at a density of 1.5 × 104 cells/well and were treated
with 2.5 or 5 mg/mL OP60 for 24 h. The medium was then replaced with
FBS-free medium containing 200 μM H2O2 or 10 mM APAP followed by incubation for 24 h. The culture medium
was then collected and used for the measurement of released LDH activity
(LDHsample). The maximum amount of releasable LDH enzyme
activity in the culture (LDHhigh control) was determined
by lysing cells in 1% Triton X-100, whereas the LDH activity from
the medium of untreated cells was defined as LDHlow control. After subtracting background absorbance from all other values,
the cytotoxicity was calculated as follows:
Real-Time
PCR Analysis
Total RNA
from HepG2 cells was extracted using an RNeasy Plus Mini Kit (QIAGEN,
Hilden, Germany) according to the manufacturer’s instructions.
One microgram of total RNA was then reverse-transcribed into cDNA
using a PrimeScript RT-PCR kit (Takara, Tokyo, Japan). Real-time PCR
was performed using SYBR Premix EX Taq (Takara) on a QuantStudio 3
thermal cycler (Thermo Fisher Scientific, Waltham, MA, USA). The cDNA
levels of tested genes were normalized to the housekeeping gene β-actin mRNA expression. The sequences of the primers
are given in Table .
Western
Blotting Analysis
For the
preparation of protein extracts, HepG2 cells or liver tissues were
lysed using the RIPA Lysis Buffer System (Santa Cruz Biotechnology)
for 30 min on ice. Lysates were then centrifuged (13,000g, 15 min, 4 °C), and supernatants were collected as cell lysates.
Nuclear extracts from HepG2 cells were prepared as described previously.[36] Briefly, harvested cells were suspended in extraction
buffer containing 10 mM HEPES, pH 7.5, 150 mM NaCl, 0.6% Nonidet P-40,
1 mM EDTA, and 5 mM DTT supplemented with a proteinase-inhibitor cocktail
(Roche Applied Science). After a 20 min incubation on ice, nuclei
were pelleted by centrifugation at 13,000g for 15
min at 4 °C. The pellets were extracted with nuclear extraction
buffer containing 10 mM HEPES, pH 7.9, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, and 5 mM DTT with a proteinase-inhibitor cocktail.
The extracts were then centrifuged (13,000g, 15 min,
4 °C), and supernatants were collected as nuclear extracts. The
protein concentration of each extract was determined by performing
a Bio-Rad protein assay. Extracted proteins were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and transferred
onto a polyvinylidene difluoride (PVDF) membrane (Bio-Rad) electrophoretically.
The membranes were then blocked with PVDF Blocking Reagent (Toyobo,
Osaka, Japan) and probed with primary antibodies against γ-GCSh,
Nrf2, HO-1, Lamin B2, or β-actin followed by incubation with
horseradish peroxidase-linked secondary antibodies. The immunoreactive
bands on the membranes were visualized using Amersham ECL Prime Western
Blotting Detection Reagent (GE Healthcare, Chicago, IL, USA) and detected
with an Amersham Imager 600 (GE Healthcare). Band intensities were
then quantified using ImageJ software (National Institutes of Health,
Bethesda, MD, USA).
Measurement of Intracellular
GSH Levels
After treatment with or without OP60, cells were
rinsed twice with
phosphate-buffered saline (PBS), harvested, homogenized in 0.1 M HCl
containing 1 mM BAPS, and deproteinized with sodium perchlorate. The
concentrations of reduced and oxidized glutathione (GSH and GSSG,
respectively) were determined simultaneously by HPLC with fluorescence
detection followed by labeling with ABD-F and SBD-F, respectively.[37] Total GSH was measured via an enzymatic recycling
method using GR and DTNB.[38]
Transfection with siRNA
Silencer
Select Pre-designed siRNA for Nrf2 and negative control siRNA were
obtained from Ambion (Life Technologies, Carlsbad, CA, USA). The target
sequences for the Nrf2 siRNAs were 5′-GAAUGGUCCUAAAACACCATT-3′
(sense) and 5′-UGGUGUUUUAGGACCAUUCTG-3′ (antisense).
Reverse transfections of siRNAs into HepG2 cells were performed using
Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s protocol. In brief, HepG2 cells were maintained
in antibiotic-free medium. Each siRNA was diluted with Opti-MEM I
Reduced Serum Medium (Gibco, Carlsbad, CA, USA) and added along with
Lipofectamine RNAiMAX to a single well of a 6-well plate. After 20
min of incubation at room temperature, a suspension of 2.5 ×
105 HepG2 cells was added to obtain a 2 nM final siRNA
concentration. After 48 h of incubation, the medium was replaced with
fresh medium with or without OP60, and cells were further incubated
for 24 h. Cells were then harvested for the measurement of GSH and
total RNA preparation. The efficiency of siRNA knockdown of Nrf2 was
determined by real-time PCR.
Animals
Four-week-old
male ICR mice
were purchased from Japan SLC (Shizuoka, Japan). All the animals were
fed a standard diet and distilled water ad libitum and housed at 24
± 1 °C under a 12 h light/dark cycle for 1 week before the
experiment. All protocols for animal experimentation were approved
by the Animal Experimentation Committee of Shujitsu University (no.
028-002), and the study was conducted according to the Animal Experimentation
Guidelines of Shujitsu University. The procedures were performed as
described in our previous publications.[18,19] Mice were
randomly divided into five groups. The rice peptide groups were orally
administered OP60 (250 or 500 mg/kg body weight) via a stomach tube
daily for 7 days, whereas the control and APAP groups were administrated
saline. All mice were then fasted for 18 h before the intraperitoneal
injection of APAP (700 mg/kg) and sacrificed 6 h after APAP administration.
Blood samples were collected, and the serum was separated by centrifugation
(750g for 10 min at 4 °C) for biochemical assays,
whereas liver samples were extracted for western blot and histopathological
analyses.
Serum Biochemical Analysis
Alanine
aminotransferase (ALT) and aspartate aminotransferase (AST) levels
in the serum were measured using a Transaminase CII Test Wako kit
(Wako Pure Chemical Industries Ltd., Osaka, Japan), and the results
are expressed in Karmen units. LDH and alkaline phosphatase (ALP)
were measured using a Cytotoxicity Detection KitPLUS (Roche
Applied Science) and LabAssay ALP (Wako Pure Chemical Industries Ltd.),
respectively.
Histopathological Examination
Liver
tissues were fixed in 10% phosphate-buffered neutral formalin, dehydrated
through a graded series of alcohol (50–100%), and embedded
in paraffin. Thin sections (6 μm) were cut and stained with
H&E stain for pathological assessment via photomicroscopy (BZ-9000;
Keyence Corporation, Osaka, Japan).
Statistical
Analysis
All data are
expressed as the mean ± standard error of the mean (SEM) of at
least three independent experiments. Data were analyzed by one-way
analysis of variance (ANOVA) followed by a Student’s t-test or Dunnett’s test to determine the significance
between the groups. Data in Figure 1C–F were analyzed by two-way
ANOVA followed by Tukey’s multiple test to check the statistical
significance between different groups. p values less
than 0.05 were considered statistically significant.